AEM vs GRML

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

GRML exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 3/9 and a complete absence of revenue or profit margins. While the current ratio is abnormally high at 95.01, the ROE of -198.17% and ROA of -74.13% indicate a failure to generate any returns from assets. Technical trends are purely bearish (0/100), and long-term price performance shows a near-total loss of value over five years. The company currently operates as a speculative entity with no fundamental drivers for growth.